Feature
Feature
From scrubs to screens: Growing your patient base with social media
“What we can do for society at large is to provide our input into issues, add informed opinions where there’s controversy, and address...
Latest News
USPSTF should reconsider recommendation to lower mammogram age: Experts
The benefit is arguably small, while the harms appear quite significant.
Feature
What’s right and wrong for doctors on social media
“You have to hold yourself back when posting. Doing things like dancing in the OR are out of whack with the profession.”
Feature
Dispelling clinicians’ misconceptions about sickle cell disease
Among clinicians and their patients, widespread myths about sickle cell disease can stand in the way of adequate treatment.
Feature
Pediatrician with SCD gives her young patients hope
A Nigerian-American hematologist draws on her experience living with sickle cell disease to encourage child patients and advise colleagues.
Feature
How to get paid if your patient passes on
“That doctor-patient relationship is a very precious relationship, so you don’t want to mix that financial aspect of providing care with the...
Feature
How targeted drugs can vanquish a virulent leukemia
Targeted therapies have revolutionized the treatment of AML, yet outcomes could be better, and these costly new drugs don’t suit all patients.
Feature
Nationwide hematologists shortage: What’s being done?
Efforts are underway to alleviate an acute shortage of U.S. physicians who’ve been trained to treat hemostasis, thrombosis and other blood...
Feature
Do doctors have a legal right to work from home because of health issues or disability?
“There is now a precedent and examples all over that working from home for some is a viable alternative to working in the hospital or a clinic.”...
Feature
The top tax breaks that physicians use
“You want to maximize your retirement contributions,” says Mark Steber, the chief tax information officer for Jackson Hewitt Tax Services. “If you...
Feature
Many patients with NSCLC receive immunotherapy ‘indefinitely’ – Are they benefiting?
Without “incontrovertible evidence” that immunotherapy should stop at 2 years, “many, many, many patients and clinicians are going to favor...